FDA
approval
· 2019-10-24
FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)
Summary
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for a combination tablet of amlodipine besylate and olmesartan medoxomil under ANDA207216, en…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)